Business
Perimeter Medical Imaging AI to Present at the H.C. Wainwright & Co. 22nd Annual Global Investment Conference
TORONTO, ON / ACCESSWIRE / September 11, 2020 / Perimeter Medical Imaging AI, Inc. (TSXV:PIN...
About this update from Perimeter Medical Imaging Ai Inc
[{"type":"text","content":"Perimeter Medical Imaging AI to Present at the H.C. Wainwright & Co. 22nd Annual Global Investment ConferenceTORONTO, ON / ACCESSWIRE / September 11, 2020 / Perimeter Medical Imaging AI, Inc. (TSXV:PINK; FSE:4PC), a medical technology company driven to transform cancer surgery with ultra-high-resolution, real-time, advanced imaging tools to address areas of high unmet medical need, announced today that Jeremy Sobotta, Perimeter's President and CFO will present a company overview at the H.C. Wainwright & Co. 22nd Annual Global Investment (Virtual) Conference on Wednesday, September 16, 2020 at 2:30 p.m. EDT.The live presentation will be webcast and may be accessed on Perimeter's website under the \"Investors\" section at https://ir.perimetermed.com/. A replay of the presentation will be available on the website and archived for approximately three months following the event.About Perimeter Medical Imaging AI, Inc. Perimeter Medical Imaging AI (TSXV:PINK; FSE:4PC) is a Toronto-based company with U.S. headquarters in Dallas, Texas that is developing, with plans to commercialize, advanced imaging tools that allow surgeons, radiologists, and pathologists to visualize microscopic tissue structures during a clinical procedure. Perimeter's OTIS™ platform is a point-of-care imaging system that provides clinicians with real-time, ultra-high-resolution, sub-surface image volumes of the margin (1-2 mm below the surface) of an excised tissue specimen.The ability to visualize microscopic tissue structures during a clinical procedure in addition to standard of care tissue assessment for decision making during the procedure has the potential to result in better long-term outcomes for patients and lower costs to the healthcare system. Perimeter's OTIS™ platform is cleared by FDA as an imaging tool in the evaluation of excised human tissue microstructure by providing two-dimensional, cross-sectional, real-time depth visualization, with image review manipulation software for identifying and annotating regions of interest. In addition, Perimeter is developing advanced artificial intelligence/machine learning image assessment tools intended to increase the efficiency of review.Perimeter's ticker symbol \"PINK\" is a reference to the pink ribbons used during Breast Cancer Awareness Month by the Canadian Cancer Society and the Americ...